Europe 3D Bioprinting market was valued at $361.8 million in 2021 and will grow by 19.1% annually over 2021-2031, driven by the increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to the aging population, the rising requirement for regenerative medicines/cancer therapeutics/stem cell solutions, the rising governments and private funding, and the technological advancements such as the development of AI and organ-on-a-chip.
Highlighted with 39 tables and 56 figures, this 130-page report “Europe 3D Bioprinting Market 2021-2031 by Component (Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices), Technology (Inkjet, Laser-assisted, Magnetic, Microextrusion), Application (Research, Clinical), End User (Research Organization, Biopharma Companies, Hospitals), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe 3D Bioprinting market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Highlighted with 39 tables and 56 figures, this 130-page report “Europe 3D Bioprinting Market 2021-2031 by Component (Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices), Technology (Inkjet, Laser-assisted, Magnetic, Microextrusion), Application (Research, Clinical), End User (Research Organization, Biopharma Companies, Hospitals), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe 3D Bioprinting market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- 3D Bioprinters
- Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
Based on Material, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Living Cells
- Hydrogels
- Extracellular Matrices
- Other Material Types
By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Inkjet 3D Bioprinting
- Laser-assisted Bioprinting
- Magnetic 3D Bioprinting
- Microextrusion Bioprinting
- Other Technologies
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Research Application
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
Clinical Application
- Skin
- Bone and Cartilage
- Blood Vessels
- Other Clinical Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Research Organization & Academic Institutes
- Biopharmaceutical Companies
- Hospitals
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
- 3D Bio-printing Solutions
- 3D Systems Inc.
- 3DBio Therapeutics
- Advanced Solutions Life Sciences LLC (ASI)
- Aspect Biosystems Ltd.
- Bico Group AB
- Brinter
- Cellink AB
- CollPlant Biotechnologies Ltd.
- Cyfuse Biomedical K. K.
- Digilab Inc.
- EnvisionTEC GmbH (Desktop Metal Inc.)
- Foldink Life Science Technologies
- GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
- Inventia Life Science Pty Ltd.
- Nano3D Biosciences Inc.
- Organovo Holdings Inc
- Pandorum Technologies Pvt. Ltd.
- Poietis
- Precise Bio
- Prellis Biologics
- Regemat 3D S.L.
- RegenHU SA
- Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
- ROKIT Healthcare, INC.
- Stratasys Ltd.
- TeVido BioDevices, Inc.
- Vivax Bio, LLC
Frequently Asked Questions about the European 3D Bioprinting Market
What is the estimated value of the European 3D Bioprinting Market?
What is the growth rate of the European 3D Bioprinting Market?
What is the forecasted size of the European 3D Bioprinting Market?
Who are the key companies in the European 3D Bioprinting Market?
Report Attribute | Details |
---|---|
No. of Pages | 130 |
Published | December 2022 |
Forecast Period | 2021 - 2031 |
Estimated Market Value ( USD | $ 361.8 Million |
Forecasted Market Value ( USD | $ 2071.4 Million |
Compound Annual Growth Rate | 19.1% |
Regions Covered | Europe |
Table of Contents
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of Europe Market by Component
4 Segmentation of Europe Market by Material
5 Segmentation of Europe Market by Technology
6 Segmentation of Europe Market by Application
7 Segmentation of Europe Market by End User
8 European Market 2021-2031 by Country
9 Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- 3D Bio-printing Solutions
- 3D Systems Inc.
- 3DBio Therapeutics
- Advanced Solutions Life Sciences LLC (ASI)
- Aspect Biosystems Ltd.
- Bico Group AB
- Brinter
- Cellink AB
- CollPlant Biotechnologies Ltd.
- Cyfuse Biomedical K. K.
- Digilab Inc.
- EnvisionTEC GmbH (Desktop Metal Inc.)
- Foldink Life Science Technologies
- GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
- Inventia Life Science Pty Ltd.
- Nano3D Biosciences Inc.
- Organovo Holdings Inc
- Pandorum Technologies Pvt. Ltd.
- Poietis
- Precise Bio
- Prellis Biologics
- Regemat 3D S.L.
- RegenHU SA
- Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
- ROKIT Healthcare, INC.
- Stratasys Ltd.
- TeVido BioDevices, Inc.
- Vivax Bio, LLC
Methodology
LOADING...